查詢結果分析
相關文獻
- Radiation Therapy in Extranodal Non-Hodgkin's Lymphoma of the Head and Neck
- Prognostic Factors in Node-Negative Breast Cancer Patients: The Experience in Taiwan
- Postoperative Radiotherapy of Adult Supratentorial High-grade Astrocytoma
- 成人低惡性度顱內星狀細胞瘤之術後放射治療
- Detection of Serum Anti-p53 Antibody in Patients with Renal Cell Carcinoma
- 乳癌預後因子探討--論流式細胞分析儀在乳癌之應用
- Prognostic Factors and Results of Radiotherapy for Brain Stem Gliomas
- Prognostic Value of DNA Ploidy Patterns of Colorectal Adenocarcinoma
- Anastomosis Leakage after Curative Resection for Mid and Low Rectal Cancer: A Poor Prognostic Factor?
- 第四期鼻咽癌的預後因子
頁籤選單縮合
題 名 | Radiation Therapy in Extranodal Non-Hodgkin's Lymphoma of the Head and Neck=頭頸部淋巴結外非何杰金氏淋巴癌之放射線治療 |
---|---|
作 者 | 高忠恕; 詹建勝; 張慶雄; 林進清; 曾顯群; 翁益強; | 書刊名 | 放射治療與腫瘤學 |
卷 期 | 4:2 1997.06[民86.06] |
頁 次 | 頁77-81 |
分類號 | 416.36 |
關鍵詞 | 預後因子; 急性副作用; Prognostic factors; Acute radiation toxicities; |
語 文 | 英文(English) |
英文摘要 | 目的:研究各項有關頭頸部淋巴結外非何杰金氏淋巴癌之預後因子。材料與方法 :自 1984 年 6 月至 1992 年 4 月,共有 22 位罹患淋巴結外非何杰金氏淋巴癌之病患於 本科接受放射線治療。 其中男性 16 位,女性 6 位,年齡介於 14 至 79 歲之間,追蹤期 間為 6 至 133 個月。使用之機器為鈷六十遠隔治療,6 或 10 百萬伏特之直線加速器,放 射治療總劑量為 2998 至 7001 cGy。 經由回溯整理其治療記錄及病歷來研究各項預後因子 。 結果:本文分析相關之預後因子,發現腫瘤之分期 (Ann Arbor stage) 為影響預後之主 要因素。整體之五年存活率為 57%。治療失敗包括有八名病患發生遠端復發,三名病患在原 發部位復發,以及一名病患在鄰近之淋巴結復發。主要死因為遠端復發。腫瘤分期第一期之 五年存活期可達到 88%,第二、三、四期之五年存活期則分別為 53%,0%,0%。放射治療之 急性副作用以黏膜及唾液腺為主。結論:早期頭頸部淋巴結外非何杰金氏淋巴癌之治療以放 射線治療可以獲得相當不錯的結果。 至於其僚預後因子之分析則有待未來更多資料收集。[ 放射治療與腫瘤學 1997;4:77-84] ults: The most common acute radiation reactions occurred at mucous membrane and salivary gland. The overall 5-year disease-specific survival rate was 57%. Treatment failures included distant relapse (8 patients), relapse in primary site (3 patients) and regional LN (1 patient). The major cause of death was distant relapse. The Ann Arbor stage was the only significant prognostic factor in this study. The 5-year disease-specific survial was excellent for stage 1 disease (88%) and the survival rates for stage II, III, and IV were 53%, 0%, and 0%, respectively. Conclusion: Non-Hodgkin's lymphoma arising from extranodal sites in the head and neck area was uncommon. The most significant prognostic factor was extent of the disease (Ann Arbor stage). Proper management of patients with early stage non-Hodgkin's lymphoma of the head and neck area remains controversial. However, excellent survival for stage I non-Hodgkin's lymphoma in the head and neck arising from extranodal sites was achievable by radiation therapy in this study. [Therapeut Radiol Oncol 1997; 4:77-84] |
本系統中英文摘要資訊取自各篇刊載內容。